SYMBYX announces promising Sydney Adventist Hospital clinical trial results for Parkinson’s using the SYMBYX Neuro – a new light therapy wellness helmet

Posted on by

SYDNEY, March 17, 2023 /PRNewswire/ — SYMBYX, an Australian medtech company developing light therapies for intractable disease conditions, today announced the results of a Sydney Adventist Hospital (commonly known as the San) triple-blinded, randomised controlled trial investigating the…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.